217 related articles for article (PubMed ID: 23047754)
1. Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.
Couch BA; Kerrisk ME; Kaufman AC; Nygaard HB; Strittmatter SM; Koleske AJ
J Comp Neurol; 2013 Apr; 521(6):1395-408. PubMed ID: 23047754
[TBL] [Abstract][Full Text] [Related]
2. Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice.
Hascup KN; Findley CA; Britz J; Esperant-Hilaire N; Broderick SO; Delfino K; Tischkau S; Bartke A; Hascup ER
J Neurochem; 2021 Feb; 156(4):513-523. PubMed ID: 33107040
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.
O'Neal-Moffitt G; Delic V; Bradshaw PC; Olcese J
Mol Neurodegener; 2015 Jul; 10():27. PubMed ID: 26159703
[TBL] [Abstract][Full Text] [Related]
4. Novel object recognition as a facile behavior test for evaluating drug effects in AβPP/PS1 Alzheimer's disease mouse model.
Zhang R; Xue G; Wang S; Zhang L; Shi C; Xie X
J Alzheimers Dis; 2012; 31(4):801-12. PubMed ID: 22710911
[TBL] [Abstract][Full Text] [Related]
5. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
6. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
7. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
8. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic Preconditioning Ameliorates Amyloid-β Pathology and Longterm Cognitive Decline in AβPP/PS1 Transgenic Mice.
Zhang J; Zhang J; Li XJ; Xiao J; Ye F
Curr Alzheimer Res; 2020; 17(7):626-634. PubMed ID: 33030131
[TBL] [Abstract][Full Text] [Related]
10. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
[TBL] [Abstract][Full Text] [Related]
13. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
14. Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse.
Plucińska K; Crouch B; Yeap JM; Stoppelkamp S; Riedel G; Platt B
J Alzheimers Dis; 2018; 65(1):165-180. PubMed ID: 30040726
[TBL] [Abstract][Full Text] [Related]
15. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D
J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316
[TBL] [Abstract][Full Text] [Related]
16. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
[TBL] [Abstract][Full Text] [Related]
17. An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.
Lim S; Choi JG; Moon M; Kim HG; Lee W; Bak HR; Sung H; Park CH; Kim SY; Oh MS
J Alzheimers Dis; 2016; 50(1):189-200. PubMed ID: 26639976
[TBL] [Abstract][Full Text] [Related]
18. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
[TBL] [Abstract][Full Text] [Related]
19. Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
Zhao Y; Bao J; Liu W; Gong X; Liang Z; Li W; Wu M; Xiao Y; Sun B; Wang X; Wang JZ; Wang J; Shu X
J Alzheimers Dis; 2022; 85(4):1453-1466. PubMed ID: 34958016
[TBL] [Abstract][Full Text] [Related]
20. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
